Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9

FDA recall notice · announced June 9, 2021 · Hi Tech Pharmaceuticals

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9

Reason for recall

The firm was notified by the FDA that the product contains the unapproved food additive 1,4-dimethylamylamine (DMAA).

Notes

Distribution: The product was shipped to the following states: AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MO, MS, MT, NC, NE, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, TN, TX, UT, VA, VT, WA & WI.
Lot/code information: Lot # 001211197, Exp. 12/25
Quantity: 19,068/100 ct bottles
Status: Ongoing
Products in this recall event:
- Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9 (F-0647-2021)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.